Cargando…
Exome-wide association study of treatment-resistant depression suggests novel treatment targets
Treatment-resistant depression (TRD) is a severe form of major depressive disorder (MDD) with substantial public health impact and poor treatment outcome. Treatment outcome in MDD is significantly heritable, but genome-wide association studies have failed to identify replicable common marker alleles...
Autores principales: | Shah, Shrey B., Peddada, Teja N., Song, Christopher, Mensah, Maame, Sung, Heejong, Yavi, Mani, Yuan, Peixiong, Zarate, Carlos A., Mickey, Brian J., Burmeister, Margit, Akula, Nirmala, McMahon, Francis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394052/ https://www.ncbi.nlm.nih.gov/pubmed/37528149 http://dx.doi.org/10.1038/s41598-023-38984-z |
Ejemplares similares
-
Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022) -
Identity-by-descent filtering as a tool for the identification of disease alleles in exome sequence data from distant relatives
por: Akula, Nirmala, et al.
Publicado: (2011) -
Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2018) -
Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
por: Guo, Wei, et al.
Publicado: (2019) -
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
por: Moaddel, Ruin, et al.
Publicado: (2022)